The article mentions that Progyny has received 2 bullish and 3 somewhat bullish ratings from analysts in the last quarter. This indicates a positive sentiment towards the stock. The average 12-month price target of $49.4, with a high of $58.00 and a low of $44.00, suggests potential growth in the short term. The increase in the average price target by 2.21% over the past month also supports this positive outlook.